Interpace Biosciences
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
IDXG Key Statistics
Stock Snapshot
The current Interpace Biosciences(IDXG) stock price is $1.70, with a market capitalization of 64.93M. The stock trades at a price-to-earnings (P/E) ratio of 0.00 and offers a dividend yield of 0.0%.
On 2026-03-12, Interpace Biosciences(IDXG) stock moved within a range of $1.70 to $1.70. With shares now at $1.70, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Interpace Biosciences(IDXG) stock has reached 1, versus its average volume of 573.44K.
Over the past 52 weeks, Interpace Biosciences(IDXG) stock has traded between a high of $1.70 and a low of $0.38.
Over the past 52 weeks, Interpace Biosciences(IDXG) stock has traded between a high of $1.70 and a low of $0.38.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.